Universidad de La Frontera
Temuco, Cautín, 4780000, Chile
Location contact
Camila Venegas, MSc
CONTACT
Ramón Fuentes, PhD
CONTACT
Ramón Fuentes, PhD
PRINCIPAL_INVESTIGATOR
NCT Number: NCT07692828
The purpose of this clinical trial is to test a nutritional intervention. This study helps older adults who wear complete removable dentures improve their health.
The main questions the study aims to answer are:
* What are the participants life experiences living with complete dentures before the intervention? * Does the intervention improve the diet quality of the participants? * Does the intervention improve nutritional status of the participants? * Does the intervention improve chewing performance and muscle strength? * Does the intervention increase the thickness of the masticatory muscles? * Does the intervention improve stress and muscle health markers in saliva? * Does the intervention improve cognitive performance and oral health-related quality of life? * Does the intervention improve cerebral blood flow? The study will include a total of 40 participants, who will be assigned to two groups. One group of 20 participants will receive the nutritional intervention, while the other group of 20 participants will maintain their usual diet during the study period. This comparison will allow the investigators to assess the effectiveness of the intervention.
Participants will:
* Take part in a personal interview about their life experience with dentures. * Follow a dietary guide with recommendations on specific food textures for six months. * Receive personalized nutritional counseling and participate in healthy cooking workshops. * Use a custom-built mobile application to access the educational content of the nutritional guide, view instructional videos uploaded biweekly, and receive automated reminder notifications. * Attend clinical follow-up assessments, including chewing performance, muscle assessment, saliva markers, assessment of diet quality and nutritional status, cognitive tests, and oral health-related quality of life. * Complete these assessments at three main time points: baseline, 3 months, and 6 months.
Trial opening soon.
Get Notified60 year–80 year
All sexes
Interventional
Not applicable
Temuco, Cautín, 4780000, Chile
Camila Venegas, MSc
CONTACT
Ramón Fuentes, PhD
CONTACT
Ramón Fuentes, PhD
PRINCIPAL_INVESTIGATOR
This clinical trial evaluates the effectiveness of a multidimensional nutritional intervention on the functional, physiological, and cognitive health of older adults wearing complete removable dentures. The study employs a convergent parallel mixed-methods design to integrate quantitative with qualitative outcomes.
Participants will undergo comprehensive clinical and laboratory assessments:
The 40 participants will be randomly allocated into two balanced groups (20 participants per arm):
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
This 6-month nutritional intervention for older adults wearing complete removable dentures consists of 6 components:
Time frame: T0 (month 0), T1 (month 3) and T2 (month 6).
Measurement of food fractionation capacity. Participants will chew a standardized food (peanuts) for 20 cycles; the particles will be dried and processed through a sieving system (sieves from 4.0 mm to 870 μm) to determine the percentage of fractionation.
Time frame: T0 (month 0), T1 (month 3) and T2 (month 6).
Diet quality will be assessed using the Chilean Healthy Eating Index (Índice de Dieta Mediterránea for Chile, IDM-Chile), which allows the evaluation of adherence to healthy dietary patterns in the study population.
Time frame: Between month 0 and month 1 (collected during the initial phase of the study to capture prior experiences and avoid intervention bias).
A qualitative assessment using a Grounded Theory framework conducted through semi-structured individual interviews to explore older adults' perceptions regarding their experiences with tooth loss, rehabilitation with complete removable dental prostheses, and their natural functional and social adaptation strategies in daily life. Interviews (30-60 minutes) will be audio-recorded, transcribed verbatim, and analyzed concurrently using ATLAS.ti software through progressive coding (open, axial, and selective) to develop a substantive explanatory model.
Time frame: T0 (month 0), T1 (month 3) and T2 (month 6).
The total number of chewing cycles recorded during the mastication of a standardized food (peanuts), quantified using a 3D electromagnetic articulograph (AG501).
Time frame: T0 (month 0), T1 (month 3) and T2 (month 6).
Assessment of chewing cycles focusing on the area, measured in square millimeters (mm²) using a 3D electromagnetic articulograph (AG501).
Time frame: T0 (month 0), T1 (month 3) and T2 (month 6).
Assessment of the masticatory frequency during mastication, measured as the number of cycles per second (cycles/s) using a 3D electromagnetic articulograph (AG501).
Time frame: T0 (month 0), T1 (month 3) and T2 (month 6).
Assessment of chewing focusing on the movement velocity, measured in millimeters per second (mm/s) using a 3D electromagnetic articulograph (AG501).
Time frame: T0 (month 0), T1 (month 3) and T2 (month 6).
Measurement of maximum voluntary contraction in Newtons (N) using a digital gnathodynamometer placed between the first prosthetic molars.
Time frame: T0 (month 0) and T2 (month 6).
Evaluation of the thickness of the masseter and anterior temporalis muscles, measured in millimeters (mm) using a portable ultrasound device with a linear transducer.
Time frame: T0 (month 0) and T2 (month 6).
Laboratory analysis of saliva samples to quantify cortisol concentration, a biomarker of physiological stress, samples will be analyzed using a Synergy HT Multimodal Reader (Biotek, USA). The outcome will be determined via enzyme-linked immunosorbent assay (ELISA) and expressed in nanograms per milliliter (ng/mL).
Time frame: T0 (month 0) and T2 (month 6).
Laboratory analysis of saliva samples to quantify Insulin-like Growth Factor 1 (IGF-1) concentration, a biomarker related to muscle health and growth, samples will be analyzed using a Synergy HT Multimodal Reader (Biotek, USA). The outcome will be determined via immunoassay and expressed in picograms per milliliter (pg/mL).
Time frame: T0 (month 0) and T2 (month 6).
Laboratory analysis of saliva samples to quantify Creatine Kinase (CK) enzymatic activity, a biomarker of muscle tissue stress and health, samples will be analyzed using a Synergy HT Multimodal Reader (Biotek, USA). The outcome will be determined via spectrophotometry and expressed in Units per liter (U/L).
Time frame: T0 (month 0) and T2 (month 6).
Laboratory analysis of saliva samples to quantify general oxidative stress by measuring reactive oxygen species (ROS) content. Saliva samples will be incubated with the CH2DCFDA fluorescent probe (30 uM) for 1 hour at 37°C in the dark. Fluorescence emission will be recorded at 530 nm using a Synergy HT multimodal reader (Biotek, USA), with H2O2 (100 uM) used as a positive control. The outcome will be reported as fluorescence intensity measured in Relative Fluorescence Units (RFU), where higher RFU values indicate a higher level of general oxidative stress.
Time frame: T0 (month 0) and T2 (month 6).
Laboratory analysis of saliva samples to quantify total antioxidant capacity using the Oxygen Radical Absorbance Capacity (ORAC) method. The assay monitors the decay of fluorescein fluorescence (excitation/emission at 495/530 nm) over 120 minutes induced by AAPH free radicals, which is counteracted by the antioxidants in the sample. Readings will be captured every 2 minutes using a Synergy HT Multimodal Reader (Biotek, USA) and interpolated against a Trolox calibration curve. The outcome will be reported in millimoles of Trolox equivalents per milliliter of saliva (mmol TE/mL), where higher ORAC values indicate a greater total antioxidant capacity.
Time frame: T0 (month 0), T1 (month 3) and T2 (month 6).
Evaluation of the impact of oral health on the patient's quality of life using the OHIP-7Sp questionnaire, validated for the elderly Chilean population. Total scores range from 0 to 28, where higher scores indicate poorer oral health-related quality of life.
Time frame: T0 (month 0), T1 (month 3) and T2 (Month 6).
Evaluation of global cognitive status and its subdomains (orientation, attention, memory, language, and visuospatial skills) using the Chilean version of the Addenbrooke's Cognitive Examination (ACE). The outcome is measured using the instrument's total score, which ranges from 0 to 100 points, where higher scores indicate better global cognitive efficiency.
Time frame: T0 (month 0), T1 (month 3) and T2 (month 6).
Evaluation of executive functions, including selective attention, cognitive flexibility, inhibition, and information processing speed, administered digitally via the "EncephalApp-Stroop Test" application on a tablet. The outcome is measured as the total completion time in seconds, where shorter execution times indicate better executive performance and cognitive control.
Time frame: T0 (month 0) and T2 (month 6).
Assessment of cerebral hemodynamics at rest focusing on the mean flow velocity of the anterior and middle cerebral arteries to evaluate neurovascular coupling. Measurements will be recorded in centimeters per second (cm/s) through Transcranial Doppler ultrasonography using a PMD-100 system (Spencer Technologies, Redmond, USA) with a 2 MHz transducer at a depth of 5 cm. The assessment will be conducted by a specialized neurologist at the neurology service of the Dr. Hernán Henríquez Aravena Hospital (Temuco, Chile).
Time frame: T0 (month 0) and T2 (month 6).
Assessment of cerebral hemodynamics at rest focusing on the pulsatility of the anterior and middle cerebral arteries to evaluate neurovascular coupling and cerebrovascular resistance. The outcome will be calculated as a dimensionless ratio value through Transcranial Doppler ultrasonography using a PMD-100 system (Spencer Technologies, Redmond, USA) with a 2 MHz transducer at a depth of 5 cm. The assessment will be conducted by a specialized neurologist at the neurology service of the Dr. Hernán Henríquez Aravena Hospital (Temuco, Chile).
Time frame: T0 (month 0), T1 (month 3) and T2 (month 6).
Anthropometric evaluation of nutritional status. Participants weight (measured in kilograms) and height (measured in meters) will be aggregated to calculate and report the Body Mass Index (BMI), expressed in kilograms per square meter (kg/m²).
Time frame: T0 (month 0), T1 (month 3), and T2 (month 6).
Anthropometric assessment of abdominal fat distribution. Measurement of the participant's waist circumference, recorded in centimeters (cm) using a standardized non-elastic flexible tape measure.
Time frame: T0 (month 0), T1 (month 3) and T2 (month 6).
Evaluation of tissue body composition, specifically assessing the total body fat percentage (%), determined via bioelectrical impedance analysis (BIA).
Time frame: T0 (month 0), T1 (month 3) and T2 (month 6).
Evaluation of muscular health and body composition, specifically assessing the skeletal muscle mass percentage (%), determined via bioelectrical impedance analysis (BIA).
Contact information is provided by the study sponsor or research team.
Camila Venegas, MSc
CONTACT
Ramón Fuentes, PhD
CONTACT
Universidad de La Frontera
Other
Novel Dietary Guidelines for Elderly Denture-wearers to Ensure Adequate Nutritional Intake, Good Quality of Life and Enhanced Performance on Cognitive Tasks
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07585162
Edentulism, Edentulism Complete
View Trial DetailsNCT07723404
Edentulism, Edentulism Complete
Shibīn al Kawm, Shibin Alkom, Egypt
View Trial DetailsNCT07639112
Bite Force, Complete Dentures
Zagreb, City of Zagreb, Croatia
View Trial DetailsNCT06298786
Chewing Problem, Craniomandibular Disorders
Manresa, Barcelona, Spain
View Trial Details